Pre-order Enquiry
Request Free Sample
Global In Vitro Toxicity Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18505595 | Publishing Date : 11-Jun-2021 | No. of pages : 108
Detailed TOC of Global In Vitro Toxicity Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of In Vitro Toxicity1.1 In Vitro Toxicity Market Overview
1.1.1 In Vitro Toxicity Product Scope
1.1.2 In Vitro Toxicity Market Status and Outlook
1.2 Global In Vitro Toxicity Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global In Vitro Toxicity Market Size by Region (2016-2027)
1.4 Global In Vitro Toxicity Historic Market Size by Region (2016-2021)
1.5 Global In Vitro Toxicity Market Size Forecast by Region (2022-2027)
1.6 Key Regions, In Vitro Toxicity Market Size (2016-2027)
1.6.1 North America In Vitro Toxicity Market Size (2016-2027)
1.6.2 Europe In Vitro Toxicity Market Size (2016-2027)
1.6.3 Asia-Pacific In Vitro Toxicity Market Size (2016-2027)
1.6.4 Latin America In Vitro Toxicity Market Size (2016-2027)
1.6.5 Middle East & Africa In Vitro Toxicity Market Size (2016-2027)
2 In Vitro Toxicity Market Overview by Type
2.1 Global In Vitro Toxicity Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global In Vitro Toxicity Historic Market Size by Type (2016-2021)
2.3 Global In Vitro Toxicity Forecasted Market Size by Type (2022-2027)
2.4 Dose Response
2.5 Threshold Response
3 In Vitro Toxicity Market Overview by Application
3.1 Global In Vitro Toxicity Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global In Vitro Toxicity Historic Market Size by Application (2016-2021)
3.3 Global In Vitro Toxicity Forecasted Market Size by Application (2022-2027)
3.4 Distribution
3.5 Excretion
3.6 Metabolism
4 In Vitro Toxicity Competition Analysis by Players
4.1 Global In Vitro Toxicity Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Vitro Toxicity as of 2020)
4.3 Date of Key Players Enter into In Vitro Toxicity Market
4.4 Global Top Players In Vitro Toxicity Headquarters and Area Served
4.5 Key Players In Vitro Toxicity Product Solution and Service
4.6 Competitive Status
4.6.1 In Vitro Toxicity Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Agilent Technologies
5.1.1 Agilent Technologies Profile
5.1.2 Agilent Technologies Main Business
5.1.3 Agilent Technologies In Vitro Toxicity Products, Services and Solutions
5.1.4 Agilent Technologies In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.1.5 Agilent Technologies Recent Developments
5.2 Covance
5.2.1 Covance Profile
5.2.2 Covance Main Business
5.2.3 Covance In Vitro Toxicity Products, Services and Solutions
5.2.4 Covance In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.2.5 Covance Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Profile
5.3.2 Bio-Rad Laboratories Main Business
5.3.3 Bio-Rad Laboratories In Vitro Toxicity Products, Services and Solutions
5.3.4 Bio-Rad Laboratories In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.3.5 General Electric Recent Developments
5.4 General Electric
5.4.1 General Electric Profile
5.4.2 General Electric Main Business
5.4.3 General Electric In Vitro Toxicity Products, Services and Solutions
5.4.4 General Electric In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.4.5 General Electric Recent Developments
5.5 Eurofins Scientific
5.5.1 Eurofins Scientific Profile
5.5.2 Eurofins Scientific Main Business
5.5.3 Eurofins Scientific In Vitro Toxicity Products, Services and Solutions
5.5.4 Eurofins Scientific In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.5.5 Eurofins Scientific Recent Developments
5.6 BioReliance
5.6.1 BioReliance Profile
5.6.2 BioReliance Main Business
5.6.3 BioReliance In Vitro Toxicity Products, Services and Solutions
5.6.4 BioReliance In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.6.5 BioReliance Recent Developments
5.7 Charles River Laboratories International
5.7.1 Charles River Laboratories International Profile
5.7.2 Charles River Laboratories International Main Business
5.7.3 Charles River Laboratories International In Vitro Toxicity Products, Services and Solutions
5.7.4 Charles River Laboratories International In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.7.5 Charles River Laboratories International Recent Developments
5.8 Thermo Fisher Scientific
5.8.1 Thermo Fisher Scientific Profile
5.8.2 Thermo Fisher Scientific Main Business
5.8.3 Thermo Fisher Scientific In Vitro Toxicity Products, Services and Solutions
5.8.4 Thermo Fisher Scientific In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.8.5 Thermo Fisher Scientific Recent Developments
5.9 Catalent
5.9.1 Catalent Profile
5.9.2 Catalent Main Business
5.9.3 Catalent In Vitro Toxicity Products, Services and Solutions
5.9.4 Catalent In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.9.5 Catalent Recent Developments
5.10 Cyprotex
5.10.1 Cyprotex Profile
5.10.2 Cyprotex Main Business
5.10.3 Cyprotex In Vitro Toxicity Products, Services and Solutions
5.10.4 Cyprotex In Vitro Toxicity Revenue (US$ Million) & (2016-2021)
5.10.5 Cyprotex Recent Developments
6 North America
6.1 North America In Vitro Toxicity Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe In Vitro Toxicity Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Toxicity Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In Vitro Toxicity Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Toxicity Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In Vitro Toxicity Market Dynamics
11.1 In Vitro Toxicity Industry Trends
11.2 In Vitro Toxicity Market Drivers
11.3 In Vitro Toxicity Market Challenges
11.4 In Vitro Toxicity Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global In Vitro Toxicity Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market In Vitro Toxicity Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global In Vitro Toxicity Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global In Vitro Toxicity Market Size Share by Region (2016-2021)
Table 4. Global In Vitro Toxicity Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global In Vitro Toxicity Forecasted Market Size Share by Region (2022-2027)
Table 6. Global In Vitro Toxicity Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global In Vitro Toxicity Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global In Vitro Toxicity Revenue Market Share by Type (2016-2021)
Table 9. Global In Vitro Toxicity Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global In Vitro Toxicity Revenue Market Share by Type (2022-2027)
Table 11. Global In Vitro Toxicity Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global In Vitro Toxicity Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global In Vitro Toxicity Revenue Market Share by Application (2016-2021)
Table 14. Global In Vitro Toxicity Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global In Vitro Toxicity Revenue Market Share by Application (2022-2027)
Table 16. Global In Vitro Toxicity Revenue (US$ Million) by Players (2016-2021)
Table 17. Global In Vitro Toxicity Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Vitro Toxicity as of 2020)
Table 19. Date of Key Manufacturers Enter into In Vitro Toxicity Market
Table 20. Global In Vitro Toxicity Top Players Headquarters and Area Served
Table 21. In Vitro Toxicity Product Solution and Service
Table 22. Global In Vitro Toxicity Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Agilent Technologies Basic Information List
Table 25. Agilent Technologies Description and Business Overview
Table 26. Agilent Technologies In Vitro Toxicity Products, Services and Solutions
Table 27. Revenue (US$ Million) in In Vitro Toxicity Business of Agilent Technologies (2016-2021)
Table 28. Agilent Technologies Recent Developments
Table 29. Covance Basic Information List
Table 30. Covance Description and Business Overview
Table 31. Covance In Vitro Toxicity Products, Services and Solutions
Table 32. Revenue (US$ Million) in In Vitro Toxicity Business of Covance (2016-2021)
Table 33. Covance Recent Developments
Table 34. Bio-Rad Laboratories Basic Information List
Table 35. Bio-Rad Laboratories Description and Business Overview
Table 36. Bio-Rad Laboratories In Vitro Toxicity Products, Services and Solutions
Table 37. Revenue (US$ Million) in In Vitro Toxicity Business of Bio-Rad Laboratories (2016-2021)
Table 38. Bio-Rad Laboratories Recent Developments
Table 39. General Electric Basic Information List
Table 40. General Electric Description and Business Overview
Table 41. General Electric In Vitro Toxicity Products, Services and Solutions
Table 42. Revenue (US$ Million) in In Vitro Toxicity Business of General Electric (2016-2021)
Table 43. General Electric Recent Developments
Table 44. Eurofins Scientific Basic Information List
Table 45. Eurofins Scientific Description and Business Overview
Table 46. Eurofins Scientific In Vitro Toxicity Products, Services and Solutions
Table 47. Revenue (US$ Million) in In Vitro Toxicity Business of Eurofins Scientific (2016-2021)
Table 48. Eurofins Scientific Recent Developments
Table 49. BioReliance Basic Information List
Table 50. BioReliance Description and Business Overview
Table 51. BioReliance In Vitro Toxicity Products, Services and Solutions
Table 52. Revenue (US$ Million) in In Vitro Toxicity Business of BioReliance (2016-2021)
Table 53. BioReliance Recent Developments
Table 54. Charles River Laboratories International Basic Information List
Table 55. Charles River Laboratories International Description and Business Overview
Table 56. Charles River Laboratories International In Vitro Toxicity Products, Services and Solutions
Table 57. Revenue (US$ Million) in In Vitro Toxicity Business of Charles River Laboratories International (2016-2021)
Table 58. Charles River Laboratories International Recent Developments
Table 59. Thermo Fisher Scientific Basic Information List
Table 60. Thermo Fisher Scientific Description and Business Overview
Table 61. Thermo Fisher Scientific In Vitro Toxicity Products, Services and Solutions
Table 62. Revenue (US$ Million) in In Vitro Toxicity Business of Thermo Fisher Scientific (2016-2021)
Table 63. Thermo Fisher Scientific Recent Developments
Table 64. Catalent Basic Information List
Table 65. Catalent Description and Business Overview
Table 66. Catalent In Vitro Toxicity Products, Services and Solutions
Table 67. Revenue (US$ Million) in In Vitro Toxicity Business of Catalent (2016-2021)
Table 68. Catalent Recent Developments
Table 69. Cyprotex Basic Information List
Table 70. Cyprotex Description and Business Overview
Table 71. Cyprotex In Vitro Toxicity Products, Services and Solutions
Table 72. Revenue (US$ Million) in In Vitro Toxicity Business of Cyprotex (2016-2021)
Table 73. Cyprotex Recent Developments
Table 74. North America In Vitro Toxicity Market Size by Country (2016-2021) & (US$ Million)
Table 75. North America In Vitro Toxicity Market Size by Country (2022-2027) & (US$ Million)
Table 76. Europe In Vitro Toxicity Market Size by Country (2016-2021) & (US$ Million)
Table 77. Europe In Vitro Toxicity Market Size by Country (2022-2027) & (US$ Million)
Table 78. Asia-Pacific In Vitro Toxicity Market Size by Region (2016-2021) & (US$ Million)
Table 79. Asia-Pacific In Vitro Toxicity Market Size by Region (2022-2027) & (US$ Million)
Table 80. Asia-Pacific In Vitro Toxicity Market Share by Region (2016-2021)
Table 81. Asia-Pacific In Vitro Toxicity Market Share by Region (2022-2027)
Table 82. Latin America In Vitro Toxicity Market Size by Country (2016-2021) & (US$ Million)
Table 83. Latin America In Vitro Toxicity Market Size by Country (2022-2027) & (US$ Million)
Table 84. Middle East & Africa In Vitro Toxicity Market Size by Players (2016-2021) & (US$ Million)
Table 85. Middle East & Africa In Vitro Toxicity Market Size by Country (2022-2027) & (US$ Million)
Table 86. In Vitro Toxicity Market Trends
Table 87. In Vitro Toxicity Market Drivers
Table 88. In Vitro Toxicity Market Challenges
Table 89. In Vitro Toxicity Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vitro Toxicity Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global In Vitro Toxicity Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global In Vitro Toxicity Market Share by Regions: 2021 VS 2027
Figure 4. Global In Vitro Toxicity Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America In Vitro Toxicity Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe In Vitro Toxicity Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific In Vitro Toxicity Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America In Vitro Toxicity Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa In Vitro Toxicity Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global In Vitro Toxicity Market Size Share by Type in 2021 & 2027
Figure 11. Dose Response Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Threshold Response Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Global In Vitro Toxicity Market Size Share by Application in 2021 & 2027
Figure 14. Distribution Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Excretion Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Metabolism Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. In Vitro Toxicity Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 18. Global Top 5 and Top 10 Players In Vitro Toxicity Market Share in 2020
Figure 19. North America In Vitro Toxicity Market Share by Country (2016-2027)
Figure 20. United States In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 21. Canada In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 22. Germany In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 23. France In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 24. U.K. In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 25. Italy In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 26. Russia In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 27. Nordic In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 28. Rest of Europe In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 29. Asia-Pacific In Vitro Toxicity Market Share by Region (2016-2027)
Figure 30. China In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 31. Japan In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 32. South Korea In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 33. Southeast Asia In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 34. India In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 35. Australia In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 36. Rest of Asia-Pacific In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 37. Latin America In Vitro Toxicity Market Share by Country (2016-2027)
Figure 38. Mexico In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 39. Brazil In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 40. Rest of Latin America In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 41. Middle East & Africa In Vitro Toxicity Market Share by Country (2016-2027)
Figure 42. Turkey In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 43. Saudi Arabia In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 44. UAE In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 45. Rest of Middle East & Africa In Vitro Toxicity Market Size (2016-2027) & (US$ Million)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Keyplayers in Global In Vitro Toxicity Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
Agilent TechnologiesCovance
Bio-Rad Laboratories
General Electric
Eurofins Scientific
BioReliance
Charles River Laboratories International
Thermo Fisher Scientific
Catalent
Cyprotex
Request Sample
Request Discount
